02.jpg
Melanoma Patients Australia

Home arrow Information arrow Latest News arrow New! PLX [BRAF] Trial Opening Soon in Australia!

New! PLX [BRAF] Trial Opening Soon in Australia!
Written by Lisa McFadyen   
Sunday, 20 June 2010

A new study with a BRAF V600 inhibitor (PLX3603) opening and that is posted in roche-trials.com and will be also in the next few days in clinicaltrials.gov

The study is in Australia and Europe.

http://www.roche-trials.com/trialDetailsGet.action?studyNumber=NP25247&diseaseCategoryId=58&divisionName=PHA.

This is a non-randomized trial, so you will get the "real" thing as well as other agents in the pharmokinetics based trial.